| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |